Drug
Cd5789 50 G G
Cd5789 50 G G: highest development phase Phase 3, developed by Galderma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Galderma
Trials
| Drug | Phase | Indication |
|---|---|---|
| CD5789 (trifarotene) 50µg/g Cream NCT02556788 | Phase 3 | Acne Vulgaris |
Latest
No recent events.
Follow Cd5789 50 G G on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.